The Japanese Journal of Pharmacology
Online ISSN : 1347-3506
Print ISSN : 0021-5198
ISSN-L : 0021-5198
Novel Benzodioxan Derivative, 5-{ 3- [((2S)-1, 4-Benzodioxan-2-ylmethyl)amino] propoxy} -1, 3-benzodioxole HC1 (MKC-242), with a Highly Potent and Selective Agonist Activity at Rat Central SerotoninlA Receptors
Toshio MatsudaTakashi YoshikawaMakoto SuzukiShoichi AsanoPranee SomboonthumKazuhiro TakumaYoshihide NakanoTomoko MoritaYukiko NakasuHye Sun KimMitsuo EgawaAkihiro TobeAkemichi Baba
Author information
JOURNAL FREE ACCESS

1995 Volume 69 Issue 4 Pages 357-366

Details
Abstract

The present study characterizes the neurochemical profile of the newly synthesized compound 5-{3-[((2S)-1, 4-benzodioxan-2-ylmethyl)amino]propoxy}-1, 3-benzodioxole HC1 (MKC-242). In in vitro experiments, MKC-242 had high affinity for serotonin1A (5-HT1A) receptors (K1: 0.35 nM) and moderate affinity for α1-adrenoceptors (Ki: 21 nM), whereas it had no appreciable affinity for any other neurotrans-mitter recognition sites studied and 5-HT transporter. MKC-242 (0.3-3.0 mg/kg, s.c.; 1-10 mg/kg, p.o.) caused presynaptic 5-HT1A-receptor-mediated responses (decreases in 5-HT turnover and 5-HT release) and postsynaptic 5-HT1A-receptor-mediated responses (hypothermia, an increase in serum corticosterone level and 5-HT1A behavioral syndrome). The effects of MKC-242 on decarboxylase inhibitor-induced 5-hydroxytryptophan accumulation and rectal temperature were blocked by the 5-HT1A-receptor antagonist N-tert-butyl-3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropanamide. The comparative studies on the in vivo responses induced by MKC-242 and the 5-HT1A-receptor full agonist 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) showed that MKC-242 and 8-OH-DPAT had similar efficacy at presynaptic 5-HT1A receptors, whereas the former had less efficacy than the latter at postsynaptic 5-HT1A receptors. Furthermore, MKC-242 partially inhibited forskolin-stimulated adenylate cyclase activity in hippocampal membranes. These findings suggest that MKC-242 acts as a full and partial agonist at pre- and postsynaptic 5-HT1A receptors, respectively, in the central nervous system.

Content from these authors
© The Japanese PharmacologicalSociety
Previous article Next article
feedback
Top